Navigation Links
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Date:2/18/2010

r for Drug Evaluation and Research.

FDA approved Arzerra (ofatumumab) in October 2009 for patients whose cancer is no longer being controlled by other forms of chemotherapy and Treanda (bendamustine) in March 2008 for patients with CLL who had not received prior treatment.

Rituxan is a monoclonal antibody. It is manufactured through biotechnology methods rather than by the human body's own immune system. The drug binds to the surface of cancer cells, making it easier for the patient's immune system to attack the cancer cell as if it were a foreign pathogen.

The safety and effectiveness of Rituxan was evaluated in two studies that measured progression-free survival, defined as the time a patient in the study lived without the cancer progressing.

In one study of 817 patients who had not received any prior chemotherapy, progression-free survival was eight months longer for those receiving Rituxan plus chemotherapy than for those who received chemotherapy alone. In another study of 522 persons whose cancer had progressed following other chemotherapy drugs, progression-free surv
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Advanced Prenatal Therapeutics (APT), a privately held ... alleviate the high blood pressure and other symptoms associated ... be the first medical device specifically designed to treat ... Every year, preeclampsia affects approximately 300,000 pregnant ... It is characterized by high blood pressure and proteinuria ...
(Date:5/22/2013)... , May 22, 2013   Accuray Incorporated ... its management is scheduled to present at the 2013 ... on Thursday, June 6, 2013 at 1:30 ... of the presentation will be available online from the ... . The webcast replay of the presentation ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Is There Finally A Way To Stop Severe Excessive Sweating? 2
... Discussant Focuses on Longer Duration of Remission among Patients ... Achieved with Standard Chemotherapy , , ORLANDO, June ... announced today that at the poster and discussion session ... the 2009 American Society of Clinical Oncology ("ASCO") Annual ...
... REDUCE-2 Studies Demonstrate that Novel Combination Treatment Decreases Risk ... , --Data presented today at 56th Annual Digestive ... CHICAGO, June 1 Horizon Therapeutics, Inc., a privately ... Annual Digestive Disease Week (DDW) meeting from two pivotal ...
Cached Medicine Technology:Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 2Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 3Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 4Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 5Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 6Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain 2Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain 3Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain 4Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain 5
(Date:5/22/2013)... Yoga of Lady Niguma was created by a female yogi (‘yogini’) ... the oldest yoga found in written form (in a book made ... renowned Indian master and yogi Naropa, and the yoga she created ... master. , Lady Niguma taught the practice to her student ... lineage to the second Dalai Lama, Gendun Gyatso. While researching rare ...
(Date:5/22/2013)... A new study published online today (Thursday) in the ... who visited fast food or chain restaurants in the U.S. ... likely to use calorie information given in the restaurants to ... eating at fast food or chain restaurants twice a week ... as those eating there once a week or less. , ...
(Date:5/22/2013)... Hosted by the California Dental Association Foundation and ... than $1.6 million in charitable dental services during the ... , The California Dental Association Foundation and the California ... services and oral health education to Californians who experience ... by CDA and CDAF in the past 12 months. ...
(Date:5/22/2013)... Zensah® Compression Apparel released a statement ... titled "Breast pain while running affects one-third of ... help." According to the article, a British study surveyed ... suffer from breast pain while running but do not ... , Zensah emphasizes the importance for women to ...
(Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- People ... likely to attempt suicide, whether or not they also ... a new study. "Clinicians who are seeing patients ... at increased risk of suicide," said study co-author Mark ... Resource and Evaluation Center in Ann Arbor, Mich. ...
Breaking Medicine News(10 mins):Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3
... new study from Harvard School of Public Health (HSPH) and ... between the common sexually transmitted infection, Trichomonas vaginalis ... in men. The study appears online on September 9, ... website and will appear in a later print edition. ...
... H1N1 influenza vaccine in pregnant women is launching this ... (NIAID), part of the National Institutes of Health, announced ... severe illness if they become infected with influenza virus ... to receive the seasonal influenza vaccine every year," says ...
... , , CAMARILLO, Calif., Sept. ... National Science Foundation (NSF) recently honored Dr. Blake Gillespie, Assistant ... Development (CAREER) award. , , The ... and research in protein-ligand interactions and biomolecular dynamics, is supported ...
... extend to staph infections, researchers say , WEDNESDAY, Sept. ... anti-microbial properties, might kill MRSA bacteria. , A new ... the honey, made solely from flowers found on the ... FabI protein, which is needed for fatty acid biosynthesis. ...
... to awaken dormant, common virus that crosses over into brain ... discovered part of the reason why Tysabri, a drug used ... a rare but potentially deadly brain disease in some patients. ... virus from its slumber, allowing it to cross into the ...
... , WASHINGTON, Sept. 9 Statement of ... Legal Reform, on reports from White House press secretary Robert ... tonight,s speech to Congress: , , (Logo: ... "We are encouraged that President Obama understands the tremendous ...
Cached Medicine News:Health News:Link found between common sexual infection and risk of aggressive prostate cancer 2Health News:NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women 2Health News:CI Faculty Member Awarded Nearly $1 Million NSF Grant 2Health News:MRSA May Succumb to Honey 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:U.S. Chamber Encourages Obama to Propose Meaningful Medical Liability Reforms in Speech to Congress 2
Micro-mini fiber optic light....
Miniature high intensity fiber optic light. The ultra-thin fiber-optic cable is smaller and lighter than a standard electrical cord....
... Halogen technology provides a ... is variable by 5 different ... continuously (Halogen 250). Light output ... illumination conditions (large cavity, small ...
A three lamp light source maximizes use by allowing two surgeons to work simultaneously from it, while the third lamp is reserved for backup....
Medicine Products: